129 related articles for article (PubMed ID: 10437919)
1. Acquired melanocyte stimulating hormone-inducible chemotaxis following macrophage fusion with Cloudman S91 melanoma cells.
Rachkovsky M; Pawelek J
Cell Growth Differ; 1999 Jul; 10(7):517-24. PubMed ID: 10437919
[TBL] [Abstract][Full Text] [Related]
2. Altered N-glycosylation in macrophage x melanoma fusion hybrids.
Pawelek JM; Chakraborty AK; Rachkovsky ML; Orlow SJ; Bolognia JL; Sodi SA
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1011-27. PubMed ID: 10644005
[TBL] [Abstract][Full Text] [Related]
3. Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis.
Chakraborty AK; Pawelek J; Ikeda Y; Miyoshi E; Kolesnikova N; Funasaka Y; Ichihashi M; Taniguchi N
Cell Growth Differ; 2001 Dec; 12(12):623-30. PubMed ID: 11751457
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of mRNA for the melanocortin-1 receptor but not for melanogenic proteins in macrophage x melanoma fusion hybrids exhibiting increased melanogenic and metastatic potential.
Chakraborty AK; Funasaka Y; Ichihashi M; Sodi S; Bhattacharya M; Pawelek J
Pigment Cell Res; 1999 Dec; 12(6):355-66. PubMed ID: 10614575
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-Met proto-oncogene in metastatic macrophage x melanoma fusion hybrids: implication of its possible role in MSH-induced motility.
Chakraborty AK; Kolesnikova N; Sousa Jde F; Espreafico EM; Peronni KC; Pawelek J
Oncol Res; 2003; 14(3):163-74. PubMed ID: 14760865
[TBL] [Abstract][Full Text] [Related]
6. Melanoma x macrophage hybrids with enhanced metastatic potential.
Rachkovsky M; Sodi S; Chakraborty A; Avissar Y; Bolognia J; McNiff JM; Platt J; Bermudes D; Pawelek J
Clin Exp Metastasis; 1998 May; 16(4):299-312. PubMed ID: 9626809
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of alpha and beta integrin subunits in metastatic macrophage-melanoma fusion hybrids.
Chakraborty AK; Funasaka Y; Ichihashi M; Pawelek JM
Melanoma Res; 2009 Dec; 19(6):343-9. PubMed ID: 22760065
[TBL] [Abstract][Full Text] [Related]
8. Growth and pigmentation in genetically related Cloudman S91 melanoma cell lines treated with 3-isobutyl-1-methyl-xanthine and beta-melanocyte-stimulating hormone.
Cieszka KA; Hill HZ; Hill GJ; Plonka PM
Exp Dermatol; 1995 Aug; 4(4 Pt 1):192-8. PubMed ID: 8535613
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human fibronectin polypeptide CH50 on growth and metastasis of melanoma.
Fan Q; Feng ZH; Zhang GM; Zhang H; Cao HQ
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):175-8. PubMed ID: 10437168
[TBL] [Abstract][Full Text] [Related]
10. A paracrine migration-stimulating factor for metastatic tumor cells secreted by mouse hepatic sinusoidal endothelial cells: identification as complement component C3b.
Hamada J; Cavanaugh PG; Miki K; Nicolson GL
Cancer Res; 1993 Sep; 53(18):4418-23. PubMed ID: 8364938
[TBL] [Abstract][Full Text] [Related]
11. Actions of melanotropins on mouse melanoma cell growth in vitro.
Abdel Malek ZA; Hadley ME; Bregman MD; Meyskens FL; Hruby VJ
J Natl Cancer Inst; 1986 May; 76(5):857-63. PubMed ID: 3009949
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: identification as an NH2-terminal fragment of human fibronectin.
Hu M; Pollock RE; Nicolson GL
Cancer Res; 1997 Aug; 57(16):3577-84. PubMed ID: 9270031
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression in genetically matched mouse melanoma cells with different metastatic potential.
Chakraborty AK; Yamaga S
Gene; 2003 Oct; 315():165-75. PubMed ID: 14557076
[TBL] [Abstract][Full Text] [Related]
14. Influence of a lymph node environment on invasiveness of metastatic tumor cells.
Whalen GF; Gordon C; Yeshion C; Juers D; Yurt R
J Am Coll Surg; 1994 Aug; 179(2):145-50. PubMed ID: 8044382
[TBL] [Abstract][Full Text] [Related]
15. Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanism.
Sodi SA; Chakraborty AK; Platt JT; Kolesnikova N; Rosemblat S; Keh-Yen A; Bolognia JL; Rachkovsky ML; Orlow SJ; Pawelek JM
Pigment Cell Res; 1998 Oct; 11(5):299-309. PubMed ID: 9877101
[TBL] [Abstract][Full Text] [Related]
16. Beta1,6-branched oligosaccharides regulate melanin content and motility in macrophage-melanoma fusion hybrids.
Chakraborty AK; Pawelek J
Melanoma Res; 2007 Feb; 17(1):9-16. PubMed ID: 17235237
[TBL] [Abstract][Full Text] [Related]
17. Anoikis and metastatic potential of cloudman S91 melanoma cells.
Zhu Z; Sanchez-Sweatman O; Huang X; Wiltrout R; Khokha R; Zhao Q; Gorelik E
Cancer Res; 2001 Feb; 61(4):1707-16. PubMed ID: 11245487
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a macrophage chemokinetic factor in tumor cell culture media.
Lane RD; Kaplan AM; Snodgrass MJ; Szakal AK
J Reticuloendothel Soc; 1982 Feb; 31(2):171-84. PubMed ID: 7062320
[TBL] [Abstract][Full Text] [Related]
19. Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis.
Shields JD; Emmett MS; Dunn DB; Joory KD; Sage LM; Rigby H; Mortimer PS; Orlando A; Levick JR; Bates DO
Oncogene; 2007 May; 26(21):2997-3005. PubMed ID: 17130836
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers.
Orlow SJ; Chakraborty AK; Boissy RE; Pawelek JM
Exp Cell Res; 1990 Dec; 191(2):209-18. PubMed ID: 1701721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
